INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "GLYCOENGINEERED ANTI-CD20 ANTIBODIES"

GENEVA, May 18 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/EP2025/082356) for "GLYCOENGINEERED ANTI-CD20 ANTIBODIES" on Nov 07, 2025. With publication no. WO/2026/099463, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BELIČ, Ales (Novartis farmacevtska proizvodnja d.o.o.Verovskova ulica 571000 Ljubljana), GASER, Dominik (Novartis farmacevtska proizvodnja d.o.o.Verovskova ulica 571000 Ljubljana), JAPELJ, Bostjan (Novartis farmacevtska proizvodnja d.o.o.Verovskova ulica 571000 Ljubljana)...